Characterization of a human breast cancer cell line, MCF-7/RU58R-1, resistant to the pure antiestrogen RU 58,668
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology
Link
http://link.springer.com/content/pdf/10.1007/s10549-004-5871-y.pdf
Reference46 articles.
1. Endocrine-responsive breast cancer and strategies for combating resistance
2. RU 58 668, a new pure antiestrogen inducing a regression of human mammary carcinoma implanted in nude mice
3. Exploration of the Therapeutic Potential of the Antiestrogen RU 58668 in Breast Cancer Treatment
4. Antiestrogens and Selective Estrogen Receptor Modulators as Multifunctional Medicines. 2. Clinical Considerations and New Agents
5. Fulvestrant ('Faslodex')--a new treatment option for patients progressing on prior endocrine therapy.
Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Antioxidant, Antimicrobial, Cytotoxicity, and Larvicidal Activities of Selected Synthetic Bis-Chalcones;Molecules;2022-11-25
2. Synthesis and Characterization of Chalcone-Pyridinium Hybrids as Potential Anti-Cancer and Anti-Microbial Agents;ChemistrySelect;2018-02-05
3. Control of IGFBP-2 Expression by Steroids and Peptide Hormones in Vertebrates;Frontiers in Endocrinology;2014-04-07
4. Tocotrienols and breast cancer: the evidence to date;Genes & Nutrition;2011-04-24
5. Establishment and Characterization of MACL-1 and MGSO-3 Cell Lines Derived From Human Primary Breast Cancer;Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics;2009-10-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3